Company / Operating Margin
Charles River Laboratories Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
0.6%
FY2025
5-year range
0.6% / 16.7%
FY2021-FY2025
Trend
-88.8%
vs FY2024
Sector context
#98 of 148
Health Care
What the data says
At 0.6%, Charles River Laboratories's operating margin ranks #98 of 148 in the Health Care sector. Operating Margin has fluctuated over the past 10 years, ranging from 0.6% in FY2025 to 64.7% in FY2017.
Based on SEC 10-K filings.
0.6% in FY2025 with a 5-year CAGR of -14.0%.
Declined from 16.7% to 0.6% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -14.2pp
- 5-Year Change
- -14.0pp
- 10-Year Change
- -
Sector benchmark
#98 of 148 in Health CareTop 66% of 148This company 0.6% Sector average -284.5%
▼
+100.2% above sector average
Key checks
Key Insights
- In FY2025, operating margin decreased 88.8% year-over-year.
- Currently 285.1pp above the Health Care sector average.
- Peak operating margin was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score 1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 0.6% | -88.8% |
| FY2024 | 5.6% | -66.3% |
| FY2023 | 16.7% | +12.6% |
| FY2022 | 14.8% | +10.4% |
| FY2021 | 13.4% | -8.3% |
| FY2020 | 14.6% | -5.8% |
| FY2019 | 15.5% | +6.2% |
| FY2018 | 14.6% | -77.4% |
| FY2017 | 64.7% | +357.7% |
| FY2016 | 14.1% | +8.8% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026